PBS News

Changes to mesalazine from 1 October 2019

Page last updated: 4 October 2019

On 1 October 2019, the authority requirement for item 11210B mesalazine 800 mg enteric tablet, 90  (Asacol, EU) has changed from STREAMLINED to Authority Required (Telephone), in advance of this brand of oral mesalazine delisting from the PBS on 1 April 2020.

Also as of 1 October 2019, the clinical criteria on hypersensitivity to sulphonamide or intolerance to sulfasalazine has been removed from all other oral mesalazine brands other than Asacol® (listed below), in addition to changing them from Authority Required (STREAMLINED) items to Restricted Benefit items: